IRIS
BOCCUTO, ADELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.672
NA - Nord America 1.593
AS - Asia 218
SA - Sud America 20
AF - Africa 4
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.510
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.586
GB - Regno Unito 433
IT - Italia 362
IE - Irlanda 306
SE - Svezia 149
RU - Federazione Russa 122
CN - Cina 77
FR - Francia 77
DE - Germania 73
SG - Singapore 73
UA - Ucraina 45
FI - Finlandia 30
ES - Italia 25
IN - India 23
BR - Brasile 17
BE - Belgio 16
TR - Turchia 10
IR - Iran 9
VN - Vietnam 7
GR - Grecia 6
NL - Olanda 6
JP - Giappone 5
AT - Austria 4
CA - Canada 4
CZ - Repubblica Ceca 4
PL - Polonia 4
CI - Costa d'Avorio 3
HK - Hong Kong 3
AR - Argentina 2
DK - Danimarca 2
LU - Lussemburgo 2
RS - Serbia 2
TH - Thailandia 2
AU - Australia 1
CH - Svizzera 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EU - Europa 1
GE - Georgia 1
ID - Indonesia 1
IL - Israele 1
JO - Giordania 1
KR - Corea 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
MX - Messico 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
RO - Romania 1
UZ - Uzbekistan 1
Totale 3.510
Salva come PNG Salva come JPEG
Città #
Southend 410
Dublin 303
Fairfield 221
Chandler 198
Santa Clara 133
Siena 111
Ashburn 84
Seattle 83
Woodbridge 80
Houston 72
Ann Arbor 71
Cambridge 71
Wilmington 61
Singapore 58
Princeton 54
Jacksonville 39
New York 39
Beijing 32
Milan 28
Helsinki 26
Rome 23
Málaga 22
Boardman 21
Munich 20
Brussels 16
San Mateo 16
San Diego 15
Dearborn 12
Moscow 11
Redwood City 10
Shanghai 10
Brescia 9
Council Bluffs 9
Los Angeles 9
Fremont 8
Nanjing 8
Dong Ket 7
Florence 7
London 7
Roccagorga 7
Izmir 6
Naples 6
Andover 5
North Bergen 5
Perugia 5
Zanjan 5
Bangalore 4
Cagliari 4
Frankfurt am Main 4
Lograto 4
Paris 4
Saint-Fons 4
Toronto 4
Abidjan 3
Brno 3
Dallas 3
Empoli 3
Kilburn 3
Leawood 3
Mumbai 3
Newark 3
Nuremberg 3
Padova 3
Parma 3
Pavia 3
São Paulo 3
Taranto 3
Tokyo 3
Vienna 3
Amsterdam 2
Belgrade 2
Carmignano 2
Chiswick 2
Chongqing 2
Copenhagen 2
Espoo 2
Esslingen am Neckar 2
Foggia 2
Haikou 2
Hebei 2
Hyderabad 2
Jiaxing 2
Jinan 2
Kashan 2
Kocaeli 2
Luxembourg 2
Nanchang 2
Napoli 2
Ningbo 2
Oklahoma City 2
Orangeburg 2
Redmond 2
Reggio Emilia 2
Rende 2
Romainville 2
Scandicci 2
Strigno 2
Tianjin 2
Villongo 2
Viterbo 2
Totale 2.591
Salva come PNG Salva come JPEG
Nome #
The HIV-1 reverse transcriptase E138A natural polymorphism decreases the genetic barrier to resistance to etravirine in vitro 223
Comparable in vitro activity of second-generation HIV-1 integrase strand transfer inhibitors (INSTIs) on HIV-1 clinical isolates with INSTI resistance mutations 210
Agreement between an in-house replication competent and a reference replication defective recombinant virus assay for measuring phenotypic resistance to HIV-1 protease, reverse transcriptase, and integrase inhibitors 199
DDX3X inhibitors, an effective way to overcome HIV-1 resistance 183
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 175
Performance of Geno2Pheno[coreceptor] to infer coreceptor use in human immunodeficiency virus type 1 (HIV-1) subtype A 165
Synthesis and Antiviral Activity of Novel 1,3,4-Thiadiazole Inhibitors of DDX3X 164
The HIV-1 integrase E157Q polymorphism per se does not alter susceptibility to raltegravir and dolutegravir in vitro 163
Development of an internally controlled quantitative PCR to measure total cell-associated HIV-1 DNA in blood 163
Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro 160
In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations 152
Exploring the implication of DDX3X in DENV infection: discovery of the first-in-class DDX3X fluorescent inhibitor 140
Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro 140
Development of a Cell-Based Immunodetection Assay for Simultaneous Screening of Antiviral Compounds Inhibiting Zika and Dengue Virus Replication. 120
Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus and Human Rhinoviruses 110
Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose 103
Novel antiviral strategies against emerging viral diseases 102
Zika virus in west africa: A seroepidemiological study between 2007 and 2012 102
Unique domain for a unique target: selective inhibitors of host cell DDX3X to fight emerging viruses 96
The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects 93
Decreased neutralization of the Eta SARS-CoV-2 variant by sera of previously infected and uninfected vaccinated individuals 87
Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection 73
Sofosbuvir selects for drug-resistant amino acid variants in the zika virus RNA-dependent RNA-polymerase complex in vitro 71
Neutralizing activity of African lineage Zika virus immune sera towards Asian lineage 67
In vitro anti-sars-cov-2 activity of selected metal compounds and potential molecular basis for their actions based on computational study 66
BNT162b2 SARS-CoV-2 vaccination elicits high titers of neutralizing antibodies to both b.1 and p.1 variants in previously infected and uninfected subjects 63
In vitro susceptibility of HIV-1 CRF02_AG to temsavir, the active compound of the attachment inhibitor fostemsavir 54
Time Course of Neutralizing Antibody in Health Care Workers With Mild or Asymptomatic COVID-19 Infection 46
Piperazine-derived small molecules as potential Flaviviridae NS3 protease inhibitors. In vitro antiviral activity evaluation against Zika and Dengue viruses 40
SARS-CoV-2 Infection of Human Ovarian Cells: A Potential Negative Impact on Female Fertility 39
null 32
SARS-CoV-2 infection of human ovarian cells: an in vitro model for the detection of the virus entry into the host cells 25
Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis 9
Zika Virus Epidemiology in Selected West African Countries between 2007 and 2012 9
Totale 3.644
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.066
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.066
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020216 0 0 0 0 0 0 0 43 41 64 28 40
2020/2021574 20 31 17 80 63 64 65 60 58 58 22 36
2021/2022702 26 86 57 88 43 46 43 47 34 57 61 114
2022/2023613 41 98 71 60 46 103 32 38 49 34 25 16
2023/2024521 18 17 48 31 5 147 168 10 0 15 12 50
2024/2025584 28 40 157 51 110 77 41 80 0 0 0 0
Totale 3.644